#CARSgenTherapeutics has claimed approval in #China, its home market, for satricabtagene autoleucel (#satricel), said to be the first #CARTtherapy to be approved anywhere in the world to treat a #solidtumour.
pharmaphorum.com/news/carsgen...
#AbbVie has announced its biggest #acquisition since the $63 billion mega-merger with Allergan in 2020, agreeing to take control of #immunology specialist #ApogeeTherapeutics in a $10.9 billion deal.
#MSD's #tulisokibart has become the first anti-TL1A #antibody to help patients with a type of #inflammatoryboweldisease (IBD) achieve clinical #remission in a phase 3 trial.
buff.ly/8KAfDwW
In today’s news: pharmaphorum.com/news #news #pharma #lifesciences #pharmanews #pharmaindustry
In today’s headlines: pharmaphorum.com/news #news #pharma #lifesciences #pharmanews #pharmaindustry
One of the #antibodydrugconjugates at the heart of #Pfizer's $43 billion acquisition of Seagen three years ago has failed a keenly anticipated phase 3 trial in #lungcancer.
In a landmark decision for people with early #type1diabetes (T1D) in the #UK, #Sanofi's first-of-its-kind therapy #Tzield, which can delay progression of the disease, has been given a green light for use by the #NHS.
buff.ly/jPGDv2U
Faced with the threat of a swing in the centre of gravity for #globalbiopharma R&D towards #China, the #US has launched a concerted effort to "restore #American leadership in #clinicaltrials."
buff.ly/8ziah50
#BoehringerIngelheim is stepping up its push into #oncology with new #clinicaltrials for the pathfinder product #Hernexeos and experimental drug #obrixtamig in hard-to-treat #cancers.
buff.ly/WD04dYO
#Genpact and analyst firm #HFSResearch have published a new #globalstudy that identified four interconnected #enterprisedebts preventing organisations from unlocking their true #AIvalue.
pharmaphorum.com/news/genpact...
pharmaphorum
pharmaphorum
Video
Genpact and analyst firm HFS Research recently published a new global study identifying four enterprise debts.
